Alteration of interleukin 2 (IL-2) pharmacokinetics and function by IL-2 antibodies induced after treatment of colorectal carcinoma patients with a combination of monoclonal antibody 17-1A, granulocyte macrophage colony-stimulating factor, and IL-2

Authors :: Skog, Alh
Wadhwa, M.
Moustapha Hassan
Gharizadeh, B.
Bird, C.
Ragnhammar, P.
Thorpe, R.
Mellstedt, H.
Source :: Scopus-Elsevier, Karolinska Institutet

Tools